News
Stay up to date with our investments
Sporos Launches with $38.1 Million Series A Financing
May 06, 2021
Company intends to develop and extend its diverse pipeline of therapies for cancer and immune diseases, beginning with four entities
Leadership team includes founding chief financial officer Michael Wyzga, formerly of Genzyme
Immuneering Expands Board of Directors with Addition of Senior Biotechnology Executive Laurie Keating
April 27, 2021
Immuneering Corporation (“Immuneering”) today announced the addition of Laurie Keating to its board of directors.
Immuneering Appoints Biren Amin, M.B.A., as Chief Financial Officer
April 6, 2021
CAMBRIDGE, Mass., April 06, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation today announced the appointment of Biren Amin, M.B.A., as Chief Financial Officer.
Disease-cancelling drugs: Immuneering raises $62m in Series B round
January 19, 2021
In this article by Allie Nawrat, our co-founder and CEO Ben Zeskind discusses Immuneering’s recent financing of $62m, in an oversubscribed Series B round led by high-profile life science investors.
IMMUNEERING RAISES $20 MILLION IN OVERSUBSCRIBED SERIES A FUNDING
Jan. 22, 2020
FINANCING TO FUND IMMUNEERING’S PIPELINE INCLUDING PROGRAMS IN CANCER CACHEXIA, NEXT-GENERATION KRAS INHIBITION AND THE RAF-MEK PATHWAY, ALL DRIVEN BY ITS DISEASE CANCELLING TECHNOLOGY
IMMUNEERING COMPLETES $17 MILLION SERIES A FINANCING
Dec. 16, 2019
FUNDING TO ADVANCE RAPIDLY-GROWING PIPELINE OF CANCER MEDICINES DRIVEN BY DISEASE CANCELLING TECHNOLOGY AND EXPAND SERVICES BUSINESS
Lootcakes raises $2 million to reward VIP gamers who share their data
Aug. 20, 2020
Lootcakes has raised $2 million in venture funding to reward VIP gamers who share their data about their playing habits in a privacy-safe way. It’s like a new kind of frequent flyer rewards program.
Playco raises $100 million at $1 billion valuation for instant games across platforms
Sept. 21, 2020
Meet one of gaming’s newest unicorns. Playco has raised $100 million at a $1 billion valuation for instant games over a wide variety of platforms.